Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

December 28, 2017

Primary Completion Date

December 27, 2019

Study Completion Date

January 22, 2020

Conditions
Lumbar Disc Herniation
Interventions
DRUG

Bosinji

"Product name : Bosinji Granule Manufacturer : Tsumura \& Co. Ingredient : Bosinji granule 2.5g (Bosinji extract 1.523g)~Bosinji extract is composed of following proportion of ingredient~* Rehmannia Root 1.7g~* Achyranthes Root 1.0g~* Cornus Fruit 1.0g~* Dioscorea Rhizome 1.0g~* Psyllium Husk 1.0g~* Alisma Rhizome 1.0g~* Hoelen 1.0g~* Moutan Root Bark 1.0g~* Cinnamon Bark 0.3g~* Pulvis Aconiti Tuberis Purificatum 0.3g"

DRUG

Loxonine tab.

Product name : Loxonine tab. Manufacturer : Dong Wha Pharm. Co., Ltd Ingredient : Loxoprofen Sodium 68.1mg (Loxoprofen 60mg)

PROCEDURE

Acupuncture

"Acupuncture treatment will be performed on 20 predefined acupoint using 0.25mm x 40mm acupuncture needle. The time for needle retaining is 15 minutes.~1. Both EX-B2 of herniated intervertebral disc level, its upper level and its lower level (6 acupoints)~2. Both side BL24, BL25, BL26, EX-B7, BL28 (10 acupoints)~3. Symptomatic side GB30, GB34, BL57, ST36 (4 acupoints)"

Trial Locations (4)

13601

Dongguk University Bundang Oriental Hospital, Seongnam-si

42158

Daegu Korean Medicine Hospital of Daegu Haany University, Daegu

02447

Kyunghee University Medical Center, Seoul

05278

Kyung Hee University Hospital at Gangdong, Seoul

All Listed Sponsors
collaborator

Kyung Hee University Hospital at Gangdong

OTHER

collaborator

DongGuk University

OTHER

collaborator

Daegu Korean Medicine Hospital of Daegu Haany University

OTHER

lead

Kyunghee University Medical Center

OTHER

NCT03386149 - Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine | Biotech Hunter | Biotech Hunter